A Phase I Study of Lentivirus Transduced Acute Myeloid Leukaemic Cells (AML) Expressing B7.1 (CD80) and IL [interleukin]-2 for the Potential Enhancement of Graft Versus Leukaemia(GvL) Effect in Poor Prognosis AML
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Acute myeloid leukaemia vaccine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- Acronyms RFUSIN2AML1
- 11 Aug 2008 New trial record.
- 18 Jul 2008 Biomarkers information updated